Vital Metrix

Vital Metrix is a startup focusing on revolutionizing the real-time assessment of heart failure patients. Founded in 2013, the company received a $310.00K Seed Round investment from Vertical in October 2017. Their patented data analysis solution aims to enable non-invasive measurement of cardiac flow and pressure parameters, pending FDA clearance. This technology will facilitate more frequent evaluation and adjustment of treatment for heart failure patients, ultimately leading to more cost-effective management of the condition. The motive behind Vital Metrix's mission is staggering. With over 5 million Americans living with congestive heart failure and the associated costs exceeding $30 billion annually, the impact of their solution could be monumental. Furthermore, they are addressing a critical need due to the estimated doubling of these costs to $70 billion by 2030. On the technology front, the Vital Metrix solution integrates non-invasive measurement of pulse pressure, captured by a pulse oximeter, and patented advanced signal processing to swiftly measure cardiac output and other parameters. The easy-to-use sensors include a pulse oximeter and blood pressure cuff, sending data to the Vital Metrix server for processing by their patented algorithm. In conclusion, Vital Metrix stands as a pioneering force in the healthcare industry, with a potential to make a significant impact on heart failure management. Their innovative approach and potential to address a pressing need in the market make this startup an appealing prospect for investors seeking impactful opportunities in the healthcare technology sector.